Pictet Asset Management (UK)’s Olema Pharmaceuticals OLMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$4.57M Sell
163,135
-7,087
-4% -$202K 0.01% 873
2021
Q1
$5.65M Buy
170,222
+9,458
+6% +$405K 0.01% 806
2020
Q4
$7.73M Buy
+160,764
New +$7.54M 0.01% 712

Other funds holding OLMA

Pictet Asset Management (UK)'s OLMA Position: Q2 2021 in Review

Pictet Asset Management (UK) reduced its Olema Pharmaceuticals (OLMA) stake by 4.2% in Q2 2021, selling an estimated $202K and leaving 163,135 shares worth $4.57M. The position accounts for 0.01% of the portfolio, ranked #873.

Pictet Asset Management (UK) first reported a position in OLMA in Q4 2020 and has held it in 3 quarters since. The position peaked at $7.73M in Q4 2020. 69 funds tracked by Wall St. Rank hold OLMA as of Q2 2021.

  • Pictet Asset Management (UK) held 163,135 shares of Olema Pharmaceuticals worth $4.57M as of Q2 2021.
  • Pictet Asset Management (UK) sold 7,087 Olema Pharmaceuticals shares in Q2 2021, an estimated $202K.
  • Olema Pharmaceuticals made up 0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #873 holding.
  • Pictet Asset Management (UK) first reported a position in Olema Pharmaceuticals in Q4 2020 and has held it in 3 quarters since.
  • Pictet Asset Management (UK)'s Olema Pharmaceuticals position peaked at $7.73M in Q4 2020.
  • 69 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.